AlphaCentric Advisors LLC Decreases Stock Holdings in Microbot Medical Inc. (NASDAQ:MBOT)

Posted by Donna Armstrong on Feb 18th, 2025

AlphaCentric Advisors LLC lowered its stake in shares of Microbot Medical Inc. (NASDAQ:MBOT – Free Report) by 60.0% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 40,000 shares of the biotechnology company’s stock after selling 60,000 shares during the period. AlphaCentric Advisors LLC owned approximately 0.20% of Microbot Medical worth $45,000 as of its most recent SEC filing.

Wall Street Analyst Weigh In

Separately, HC Wainwright boosted their price objective on shares of Microbot Medical from $7.00 to $9.00 and gave the company a “buy” rating in a report on Friday, January 24th.

Check Out Our Latest Research Report on MBOT

Microbot Medical Price Performance

NASDAQ MBOT opened at $1.99 on Tuesday. The stock has a market capitalization of $40.28 million, a price-to-earnings ratio of -2.49 and a beta of 1.51. Microbot Medical Inc. has a 1-year low of $0.82 and a 1-year high of $3.38. The business’s fifty day moving average price is $1.63 and its 200-day moving average price is $1.19.

About Microbot Medical

(Free Report)

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.